301 related articles for article (PubMed ID: 36552652)
1. SLC7A11 as a Gateway of Metabolic Perturbation and Ferroptosis Vulnerability in Cancer.
Lee J; Roh JL
Antioxidants (Basel); 2022 Dec; 11(12):. PubMed ID: 36552652
[TBL] [Abstract][Full Text] [Related]
2. The Role of Cystine/Glutamate Antiporter SLC7A11/xCT in the Pathophysiology of Cancer.
Jyotsana N; Ta KT; DelGiorno KE
Front Oncol; 2022; 12():858462. PubMed ID: 35280777
[TBL] [Abstract][Full Text] [Related]
3. Patulin disrupts SLC7A11-cystine-cysteine-GSH antioxidant system and promotes renal cell ferroptosis both in vitro and in vivo.
Chen H; Cao L; Han K; Zhang H; Cui J; Ma X; Zhao S; Zhao C; Yin S; Fan L; Hu H
Food Chem Toxicol; 2022 Aug; 166():113255. PubMed ID: 35772596
[TBL] [Abstract][Full Text] [Related]
4. SLC7A11/xCT in cancer: biological functions and therapeutic implications.
Lin W; Wang C; Liu G; Bi C; Wang X; Zhou Q; Jin H
Am J Cancer Res; 2020; 10(10):3106-3126. PubMed ID: 33163260
[TBL] [Abstract][Full Text] [Related]
5. NADPH debt drives redox bankruptcy: SLC7A11/xCT-mediated cystine uptake as a double-edged sword in cellular redox regulation.
Liu X; Zhang Y; Zhuang L; Olszewski K; Gan B
Genes Dis; 2021 Nov; 8(6):731-745. PubMed ID: 34522704
[TBL] [Abstract][Full Text] [Related]
6. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
Koppula P; Zhuang L; Gan B
Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
[TBL] [Abstract][Full Text] [Related]
7. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.
Koppula P; Zhang Y; Zhuang L; Gan B
Cancer Commun (Lond); 2018 Apr; 38(1):12. PubMed ID: 29764521
[TBL] [Abstract][Full Text] [Related]
8. Pan-Cancer Analyses Confirmed the Ferroptosis-Related Gene
Lin Y; Dong Y; Liu W; Fan X; Sun Y
Int J Gen Med; 2022; 15():2501-2513. PubMed ID: 35282646
[TBL] [Abstract][Full Text] [Related]
9. Gigantol exerts anti-lung cancer activity by inducing ferroptosis via SLC7A11-GPX4 axis.
Chen P; Lv X; Zheng Z
Biochem Biophys Res Commun; 2024 Jan; 690():149274. PubMed ID: 37995455
[TBL] [Abstract][Full Text] [Related]
10. Super-enhancer-driven MLX mediates redox balance maintenance via SLC7A11 in osteosarcoma.
Guo W; Wang X; Lu B; Yu J; Xu M; Huang R; Cheng M; Yang M; Zhao W; Zou C
Cell Death Dis; 2023 Jul; 14(7):439. PubMed ID: 37460542
[TBL] [Abstract][Full Text] [Related]
11. Age-dependent oxidation of extracellular cysteine/cystine redox state (E
Zheng Y; Ritzenthaler JD; Burke TJ; Otero J; Roman J; Watson WH
Free Radic Biol Med; 2018 Apr; 118():13-22. PubMed ID: 29458149
[TBL] [Abstract][Full Text] [Related]
12. Cysteine depletion induces pancreatic tumor ferroptosis in mice.
Badgley MA; Kremer DM; Maurer HC; DelGiorno KE; Lee HJ; Purohit V; Sagalovskiy IR; Ma A; Kapilian J; Firl CEM; Decker AR; Sastra SA; Palermo CF; Andrade LR; Sajjakulnukit P; Zhang L; Tolstyka ZP; Hirschhorn T; Lamb C; Liu T; Gu W; Seeley ES; Stone E; Georgiou G; Manor U; Iuga A; Wahl GM; Stockwell BR; Lyssiotis CA; Olive KP
Science; 2020 Apr; 368(6486):85-89. PubMed ID: 32241947
[TBL] [Abstract][Full Text] [Related]
13. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer.
Liu X; Olszewski K; Zhang Y; Lim EW; Shi J; Zhang X; Zhang J; Lee H; Koppula P; Lei G; Zhuang L; You MJ; Fang B; Li W; Metallo CM; Poyurovsky MV; Gan B
Nat Cell Biol; 2020 Apr; 22(4):476-486. PubMed ID: 32231310
[TBL] [Abstract][Full Text] [Related]
14. Redox States of Protein Cysteines in Pathways of Protein Turnover and Cytoskeleton Dynamics Are Changed with Aging and Reversed by Slc7a11 Restoration in Mouse Lung Fibroblasts.
Zheng Y; Merchant ML; Burke TJ; Ritzenthaler JD; Li M; Gaweda AE; Benz FW; Roman J; Watson WH
Oxid Med Cell Longev; 2020; 2020():2468986. PubMed ID: 32587657
[TBL] [Abstract][Full Text] [Related]
15. Increased Expression of System xc- in Glioblastoma Confers an Altered Metabolic State and Temozolomide Resistance.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Cassady K; Aboody KS
Mol Cancer Res; 2016 Dec; 14(12):1229-1242. PubMed ID: 27658422
[TBL] [Abstract][Full Text] [Related]
16. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of the imbalance between proliferation and ferroptosis in pulmonary artery smooth muscle cells based on the activation of SLC7A11.
Hu P; Xu Y; Jiang Y; Huang J; Liu Y; Wang D; Tao T; Sun Z; Liu Y
Eur J Pharmacol; 2022 Aug; 928():175093. PubMed ID: 35700835
[TBL] [Abstract][Full Text] [Related]
18. The amino acid transporter SLC7A11-mediated crosstalk implicated in cancer therapy and the tumor microenvironment.
He J; Wang X; Chen K; Zhang M; Wang J
Biochem Pharmacol; 2022 Nov; 205():115241. PubMed ID: 36084707
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-mediated depletion of l-cyst(e)ine synergizes with thioredoxin reductase inhibition for suppression of pancreatic tumor growth.
Kshattry S; Saha A; Gries P; Tiziani S; Stone E; Georgiou G; DiGiovanni J
NPJ Precis Oncol; 2019; 3():16. PubMed ID: 31231686
[TBL] [Abstract][Full Text] [Related]
20. SLC7A11 Overexpression in Glioblastoma Is Associated with Increased Cancer Stem Cell-Like Properties.
Polewski MD; Reveron-Thornton RF; Cherryholmes GA; Marinov GK; Aboody KS
Stem Cells Dev; 2017 Sep; 26(17):1236-1246. PubMed ID: 28610554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]